Orencia Clinical study in Early rheumatoid Arthritis using New criteria(Efficacy and safety of MTX therapy and Abatacept/MTX combination therapy in early RA patients in daily clinical practice retrospective observation study.)
Not Applicable
Recruiting
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000011019
- Lead Sponsor
- School of Medicine, Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are inadequate by investigator's decision.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients with SDAI remission (SDAI<=3.3) at week 52
- Secondary Outcome Measures
Name Time Method Proportion of patients with Modified Total Sharp Score: mTSS , Health Assessment Questionnaire: HAQ, Disease Activity Score:DAS28 ESR and CRP, Safety at week 52